GR3020961T3 - Endothelin antagonist - Google Patents

Endothelin antagonist

Info

Publication number
GR3020961T3
GR3020961T3 GR960402316T GR960402316T GR3020961T3 GR 3020961 T3 GR3020961 T3 GR 3020961T3 GR 960402316 T GR960402316 T GR 960402316T GR 960402316 T GR960402316 T GR 960402316T GR 3020961 T3 GR3020961 T3 GR 3020961T3
Authority
GR
Greece
Prior art keywords
salt
peptide
amino acid
carbon atoms
pharmaceutically acceptable
Prior art date
Application number
GR960402316T
Other languages
English (en)
Inventor
Mitsuhiro Wakimasu
Takashi Kikuchi
Kazuki Kubo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of GR3020961T3 publication Critical patent/GR3020961T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR960402316T 1991-02-15 1996-09-05 Endothelin antagonist GR3020961T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2222091 1991-02-15
JP33723591 1991-12-19

Publications (1)

Publication Number Publication Date
GR3020961T3 true GR3020961T3 (en) 1996-12-31

Family

ID=26359402

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960402316T GR3020961T3 (en) 1991-02-15 1996-09-05 Endothelin antagonist

Country Status (7)

Country Link
US (1) US5352659A (el)
EP (1) EP0499266B1 (el)
AT (1) ATE140236T1 (el)
CA (1) CA2061246A1 (el)
DE (1) DE69212011T2 (el)
ES (1) ES2089256T3 (el)
GR (1) GR3020961T3 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962490A (en) * 1987-09-25 1999-10-05 Texas Biotechnology Corporation Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
CA2043741C (en) * 1990-06-07 2003-04-01 Kiyofumi Ishikawa Endothelin antagonistic peptide derivatives
US5736509A (en) * 1990-12-14 1998-04-07 Texas Biotechnology Corporation Cyclic peptide surface feature mimics of endothelin
EP0499266B1 (en) * 1991-02-15 1996-07-10 Takeda Chemical Industries, Ltd. Endothelin antagonist
EP0547317A1 (en) * 1991-12-19 1993-06-23 Takeda Chemical Industries, Ltd. Endothelin antagonists
US5614497A (en) * 1991-12-27 1997-03-25 Takeda Chemical Industries, Ltd. Peptide, production and use thereof
FR2687156B1 (fr) * 1992-02-12 1994-04-01 Roussel Uclaf Nouveaux derives peptidiques, procede de preparation et application a titre de medicaments de ces nouveaux derives.
CA2121724A1 (en) 1993-04-21 1994-10-22 Toshifumi Watanabe Methods and compositions for the prophylactic and/or therapeutic treatment of organ hypofunction
US6541498B2 (en) 1993-05-20 2003-04-01 Texas Biotechnology Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6342610B2 (en) 1993-05-20 2002-01-29 Texas Biotechnology Corp. N-aryl thienyl-, furyl-, and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
US6613804B2 (en) 1993-05-20 2003-09-02 Encysive Pharmaceuticals, Inc. Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
US6376523B1 (en) 1994-05-20 2002-04-23 Texas Biotechnology Corporation Benzenesulfonamides and the use thereof to modulate the activity of endothelin
US6030991A (en) * 1993-05-20 2000-02-29 Texas Biotechnology Corp. Benzenesulfonamides and the use thereof to modulate the activity of endothelin
EP0679658A4 (en) * 1993-06-25 1997-06-04 Kyowa Hakko Kogyo Kk PEPTIDE WITH ANTAGONIST EFFECT OF ENDOTHELIN.
US5977117A (en) * 1996-01-05 1999-11-02 Texas Biotechnology Corporation Substituted phenyl compounds and derivatives thereof that modulate the activity of endothelin
US5958905A (en) 1996-03-26 1999-09-28 Texas Biotechnology Corporation Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin
US5804585A (en) 1996-04-15 1998-09-08 Texas Biotechnology Corporation Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin
DE19652374A1 (de) * 1996-12-04 1998-06-10 Schering Ag Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
NZ336898A (en) 1997-04-28 2001-10-26 Texas Biotechnology Corp Sulfonamides for treatment of endothelin-mediated disorders
PT1165613E (pt) 1999-03-29 2008-07-29 Procter & Gamble Ligantes do receptor de melanocortina
US7566452B1 (en) 1999-05-04 2009-07-28 New York University Cancer treatment with endothelin receptor antagonists
ATE286051T1 (de) 1999-12-31 2005-01-15 Encysive Pharmaceuticals Inc Sulfonamide und ihre derivate, die die aktivität des endothelins modulieren
US20050175667A1 (en) * 2004-02-10 2005-08-11 Wenda Carlyle Use of endothelin antagonists to prevent restenosis
KR20080104149A (ko) * 2006-03-13 2008-12-01 엔싸이시브 파마슈티칼즈 인코퍼레이티드 확장기 심장 부전의 치료를 위한 방법 및 조성물
CA2644784A1 (en) * 2006-03-13 2007-09-20 Jinling Chen Formulations of sitaxsentan sodium
US7838250B1 (en) 2006-04-04 2010-11-23 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CA3086149A1 (en) 2006-04-04 2007-10-11 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
US20080026061A1 (en) * 2006-06-22 2008-01-31 Reichwein John F Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide
WO2010144358A1 (en) 2009-06-08 2010-12-16 Singulex, Inc. Highly sensitive biomarker panels

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8919726D0 (en) * 1989-08-31 1989-10-11 Fujisawa Pharmaceutical Co Ws7338 substances and preparation thereof
CA2032559C (en) * 1989-12-28 2001-11-06 Kiyofumi Ishikawa Endothelin antagonistic cyclic pentapeptides
CA2053895A1 (en) * 1990-02-26 1991-08-27 Mitsuhiro Wakimasu Peptide derivatives and production thereof
EP0499266B1 (en) * 1991-02-15 1996-07-10 Takeda Chemical Industries, Ltd. Endothelin antagonist

Also Published As

Publication number Publication date
CA2061246A1 (en) 1992-08-16
DE69212011D1 (de) 1996-08-14
EP0499266B1 (en) 1996-07-10
US5352659A (en) 1994-10-04
DE69212011T2 (de) 1997-01-09
ATE140236T1 (de) 1996-07-15
EP0499266A1 (en) 1992-08-19
ES2089256T3 (es) 1996-10-01

Similar Documents

Publication Publication Date Title
GR3020961T3 (en) Endothelin antagonist
GR860023B (en) Method for the preparation of peptidic derivatives with a azote polycyclic structure
AU3756497A (en) D-enzyme compositions and methods of their use
EP0277420A3 (en) Polyamide rheological additive, a solution and thickened compositions containing it
GR3018096T3 (en) Polypeptide comprising repeated cell-adhesive core sequences.
AU5188393A (en) 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
PL300747A1 (en) Method of obtaining substantially pure clavulanic acid
EP0346927A3 (en) Various n-substituted 3-piperidine carboxylic acids or n-substituted 3-pyridine-carboxylic acids and derivatives thereof
GB9211779D0 (en) Amine salts
SG42995A1 (en) Isosteric antiherpes peptide derivatives
EP0291236A3 (en) Lubricating oil compositions containing anti-wear/extreme pressure additives
NO891481D0 (no) Anvendelse av jordalkalisalter av polykarboksylsyremonoestere som alkoksyleringskatalysatorer.
EP0614908A3 (en) Method of preparation of 3-beta-aminocholanic acid derivatives.
IE891297L (en) Amino acid esters, a process for the preparation thereof,¹pharmaceuticals containing them, and the use thereof
DE69011677T2 (de) Verfahren zur herstellung von substituierten ethenen.
EP0535448A3 (en) Process and intermediates for the preparation of an antiviral agent containing a cyclobutyl group
HUT71095A (en) A process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
HU9300181D0 (en) Alpha-aryl-alpha-hydroxi-beta-imidazolinyl-propionic acid amide
EP0331756A4 (en) Agents for prophylaxis and treatment of thrombopenia
AT383811B (de) Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten
ZA869400B (en) A process for the preparation of 7alpha-acetylthiosteroids